Cancer Testing/Screening Market - Forecast(2019 - 2024)

Report Code: HCR 0078 Report Format: PDF + Excel (Delivery in 48 Hrs)
Cancer Testing/Screening Market Overview:

According to the findings by WHO, the global mortality rate due to cancer in 2018 surged to 9.6 million. The same study states that up to an astonishing 50% of cancer cases could have been prevented with effective and inexpensive programmes in initial diagnosis, screening, treatment, and palliative care. With the annual economic burden of cancer well-exceeding US$1.16 trillion, the demand for medical facilities to detect and control this intricate disease at the earliest is surfacing the global healthcare forum.[1]  Owing to this demand, the global cancer testing market or cancer screening market size is estimated to be $123 billion-$133 billion as of 2018 and is growing at a global CAGR of 4.5%-5.5% during the forecast period 2019-2025.

Cancer Testing Market Outlook:

Cancer testing or screening plays an important role in the detection of various types of cancer before the appearance of symptoms. The main aim of cancer testing is to reduce the number of deaths caused by cancer.  Early diagnosis can lead to better treatment and a greater lifespan. Some of the cancer prevention testing-screening tests include various medical imaging tests, screening mammography, endoscopy tests, and biopsy tests.

After an acute analysis of the regional market segments, the Americas is figured to be the leading region, encapsulating nearly 50%-55% of the global cancer testing market demand. The sheer affluence can be explained by the fact that alone in the United States, the number of cancer cases registered in 2018 was estimated to be 1,735,350 (1.7 million).[2]  Similarly, the Canadian Cancer Society states that about 1 in 2 Canadians will develop cancer in their lifetimes and 1 in 4 will die of the disease.[3]  Cancer screening-testing being an expensive medical procedure has found the scope of application in high-income countries only as of right now. However, government support and indigenous technologies from countries such China, India, and Japan is helping the market penetration and mass commercialization. The majority of low-income economies with inaccessible diagnosis and treatment facilities stands out as potential spots to be capitalized upon by the cancer-screening testing market players.


Cancer Screening Market Growth Drivers and Trends:

  • ‘Liquid biopsy’ is one of the latest technology emerging in the market which would help in early detection of various cancers by scanning for DNA fragments which are shed by tumor cells. Companies such SRBI healthcare, GRAIL Inc., and others are raising funds for early diagnosis of cancer.
  • In recent years, Next Generation Sequencing (NGS) is being widely used for the detection of various types of cancer. NGS allows simultaneous sequencing of targeted genomic areas in multiple samples to detect mutations. The main advantage of this method is the need of low amount of DNA or RNA.
  • Swiss startup SOPHiA Genetics has used Artificial Intelligence (AI) that takes raw genome data and studies the molecular profile of a person’s cancer to find more personalized treatment options. This technology helps the doctors to understand the cause of cancer and what best treatment can be suggested for the molecular events that are taking place in the body. It is also predicted that AI would be the future of cancer diagnostics.
  • Research and campaigns run by several organization regarding timely screening and cancer diagnosis are also disrupting the cancer-testing marketplace and progressing it towards broader commercialization. For example- Centers for Disease Control and Prevention campaign ‘Screen for Life’. American Cancer Society in 2017 invested $145 million in cancer research, $129 million in prevention information, and $80 million in detection.

Cancer Testing Market

Cancer Screening Market Players Perspective: 

Some of the major key players operating in this technological novel and advanced healthcare landscape are Dias Orin S.P.A, Epigenetics Ag, Techlab, Genextropy Inc.,  M Genomics Ltd, 20/20 GeneSystems, Inc., AB SCIEX, Abbott Laboratories, Abcodia Ltd., and Abingdon Health Ltd.


Cancer Testing Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the cancer testing/screening market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various diagnosis in cancer testing/screening market and their specific advantages.

Cancer Testing/Screening Market Report: Industry Coverage

By Cancer Type: Lung, Blood, Bone, Others

By Technique: Imaging, Endoscopy, Molecular & Genomics Testing

By Stage: TNM, Prognostic Factors, Others

The Cancer Testing/Screening Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia 

Key Questions Addressed in the Cancer Testing/Screening Market Report

1. Is the market for cancer testing/screening growing? How long will it continue to grow and at what rate? 
2. Which type of systems presents the major growth opportunities? 
3. Is there a possibility for change in the market structure over time?  
4. Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands? 
5. Do the key vendors look for partnerships to expand their businesses with respect to geography or product? 
6. What are the short-term, long-term, and medium-term growth drivers for the market? 
7. What are the short-term, medium-term, and long-term challenges for the market? 
8. What are the short-term, medium-term, and long-term opportunities for the market 
9. Who are the top players/companies of the market? 
10. What are the recent innovations in the market? 
11. How many patents have been filed by the leading players? 
12. What are the types of patents filed by the leading players? 
13. What is our Vision 2030 for cancer testing/screening market? 


A few focus points of this Research are given below:

  • Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
  • Provide an overview of the product portfolio, including product planning, development, and positioning
  • Discuss the role of technology companies in partnerships
  • Explore the regional sales activities
  • Analyze the market size and giving the forecast for current and future cancer testing/screening during the forecast 2019–2025
  • Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures.

Reference:

[1]https://www.who.int/cancer/en/
[2]https://www.cancer.gov/about-cancer/understanding/statistics
[3]https://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=on
1. Cancer Testing/Screening Market - Overview
1.1. Definitions and Scope
2. Cancer Testing/Screening Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Cancer Testing/Screening Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Cancer Testing/Screening Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Cancer Testing/Screening Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Cancer Testing/Screening Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Cancer Testing/Screening Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Cancer Testing/Screening Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Introduction 
8.3.2. Lung Cancer
8.3.3. Blood Cancer 
8.3.4. Bone Cancer
8.3.5. Gall Bladder Cancer
8.3.6. Testicular Cancer
8.3.7. Thyroid Cancer
    8.3.8. Kidney Cancer
    8.3.9. Liver Cancer
    8.3.10. Pancreatic Cancer
    8.3.11. Brain Cancer
8.3.12. Abdominal Cancer
8.3.13. Eye Cancer
8.3.14. Mouth Cancer
8.3.15. Breast Cancer
8.3.16. Cervix Cancer
8.3.17. Ovarian Cancer
8.3.18. Others
9. Cancer Testing/Screening Market – By Technique (Market Size -$Million / $Billion)
9.1. Introduction
9.2. Imaging Techniques
9.2.1. CT scan
9.2.2. MRI
9.2.3. X-ray
9.2.4. Nuclear
9.2.5. Ultrasound
9.2.6. Mammography
9.2.7. Others
9.3. Endoscopy procedure
9.3.1. Colonoscopy
9.3.2. Sigmoidoscopy
9.3.3. Others
9.4. Biopsy and cytology tests
9.4.1. Needle biopsy
9.4.2. CT-guided biopsy
9.4.3. Ultrasound-guided biopsy
9.4.4. Bone biopsy
9.4.5.Bone marrow biopsy
9.4.6.Liver biopsy
9.4.7.Kidney biopsy 
9.4.8. Aspiration biopsy
9.4.9. Prostate biopsy
9.4.10 Skin biopsy
9.4.11 Surgical biopsy
9.4.12 Others
9.5. Genomic and Molecular tests
9.5.1. Next Generation Sequencing (NGS)
9.5.2. RT- PCR
9.5.3. icroarray techniques
9.5.4. Biomarker testing
9.5.5. Others
10. Cancer Testing/Screening Market – By Stage (Market Size -$Million / $Billion)
10.1. TNM Stages
10.2. Stages 0,1,2,3,4
10.3. Prognostic Factors
10.4. Other Staging Systems
11. Cancer Testing/Screening Market – By Gender (Market Size -$Million / $Billion)
11.1. Men
11.1.1. New Born
11.1.2. Infant
11.1.3. Child
11.1.4. Adolescent
11.1.5. Adults
11.1.6. Seniors
11.2. Women
11.2.1. New Born
11.2.2. Infant
11.2.3. Child
11.2.4. Adolescent
11.2.5. Adults
11.2.6. Seniors
12. Cancer Testing/Screening - By Geography (Market Size -$Million / $Billion)
12.1. Cancer Testing/Screening Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Cancer Testing/Screening - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Cancer Testing/Screening - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Cancer Testing/Screening – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Cancer Testing/Screening Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Cancer Testing/Screening Market – Industry / Segment Competition landscape Premium
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Cancer Testing/Screening Market – Key Company List by Country Premium
16. Cancer Testing/Screening Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. Dias Orin S.P.A
16.3. Epigenetics Ag
16.4. Techlab
16.5. Positive Bioscience
16.6. Genextropy Inc.
16.7. M Genomics Ltd
16.8. 20/20 GeneSystems, Inc.
16.9. AB SCIEX
16.10. Abbott Laboratories
16.11. Abcodia Ltd.
16.12. Company 11
16.13. Company 12
16.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
17. Cancer Testing/Screening Market -Appendix
17.1. Abbreviations
17.2. Sources
18. Cancer Testing/Screening Market -Methodology Premium
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
List of Tables:
Table 1: Cancer Testing/Screening Market Overview 2019-2024
Table 2: Cancer Testing/Screening Market Leader Analysis 2018-2019 (US$)
Table 3: Cancer Testing/Screening Market Product Analysis 2018-2019 (US$)
Table 4: Cancer Testing/Screening Market End User Analysis 2018-2019 (US$)
Table 5: Cancer Testing/Screening Market Patent Analysis 2013-2018* (US$)
Table 6: Cancer Testing/Screening Market Financial Analysis 2018-2019 (US$)
Table 7: Cancer Testing/Screening Market Driver Analysis 2018-2019 (US$)
Table 8: Cancer Testing/Screening Market Challenges Analysis 2018-2019 (US$)
Table 9: Cancer Testing/Screening Market Constraint Analysis 2018-2019 (US$)
Table 10: Cancer Testing/Screening Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Cancer Testing/Screening Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Cancer Testing/Screening Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Cancer Testing/Screening Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Cancer Testing/Screening Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Cancer Testing/Screening Market Value Chain Analysis 2018-2019 (US$)
Table 16: Cancer Testing/Screening Market Pricing Analysis 2019-2024 (US$)
Table 17: Cancer Testing/Screening Market Opportunities Analysis 2019-2024 (US$)
Table 18: Cancer Testing/Screening Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Cancer Testing/Screening Market Supplier Analysis 2018-2019 (US$)
Table 20: Cancer Testing/Screening Market Distributor Analysis 2018-2019 (US$)
Table 21: Cancer Testing/Screening Market Trend Analysis 2018-2019 (US$)
Table 22: Cancer Testing/Screening Market Size 2018 (US$)
Table 23: Cancer Testing/Screening Market Forecast Analysis 2019-2024 (US$)
Table 24: Cancer Testing/Screening Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Cancer Testing/Screening Market By Type, Revenue & Volume, By Lung Cancer, 2019-2024 ($)
Table 27: Cancer Testing/Screening Market By Type, Revenue & Volume, By Blood Cancer, 2019-2024 ($)
Table 28: Cancer Testing/Screening Market By Type, Revenue & Volume, By Bone Cancer, 2019-2024 ($)
Table 29: Cancer Testing/Screening Market By Type, Revenue & Volume, By Gall Bladder Cancer, 2019-2024 ($)
Table 30: Cancer Testing/Screening Market By Type, Revenue & Volume, By Testicular Cancer, 2019-2024 ($)
Table 31: Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 32: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Imaging Techniques, 2019-2024 ($)
Table 33: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Endoscopy procedure, 2019-2024 ($)
Table 34: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Biopsy and cytology tests, 2019-2024 ($)
Table 35: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Genomic and Molecular tests, 2019-2024 ($)
Table 36: Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 37: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Surgery, 2019-2024 ($)
Table 38: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Immunotherapy, 2019-2024 ($)
Table 39: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Hormone Therapy, 2019-2024 ($)
Table 40: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Chemo Therapy, 2019-2024 ($)
Table 41: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Gene Therapy, 2019-2024 ($)
Table 42: Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 43: Cancer Testing/Screening Market By Stage, Revenue & Volume, By TNM Stages, 2019-2024 ($)
Table 44: Cancer Testing/Screening Market By Stage, Revenue & Volume, By Stages 0, 1, 2, 3, 4, 2019-2024 ($)
Table 45: Cancer Testing/Screening Market By Stage, Revenue & Volume, By Prognostic Factors, 2019-2024 ($)
Table 46: Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 47: Cancer Testing/Screening Market By Gender, Revenue & Volume, By Men, 2019-2024 ($)
Table 48: Cancer Testing/Screening Market By Gender, Revenue & Volume, By Women, 2019-2024 ($)
Table 49: North America Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 50: North America Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 51: North America Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 52: North America Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 53: North America Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 54: South america Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 55: South america Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 56: South america Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 57: South america Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 58: South america Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 59: Europe Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 60: Europe Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 61: Europe Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 62: Europe Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 63: Europe Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 64: APAC Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 65: APAC Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 66: APAC Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 67: APAC Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 68: APAC Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 69: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 70: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 71: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 72: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 73: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 74: Russia Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 75: Russia Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 76: Russia Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 77: Russia Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 78: Russia Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 79: Israel Cancer Testing/Screening Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 80: Israel Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2019-2024 ($)
Table 81: Israel Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2019-2024 ($)
Table 82: Israel Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2019-2024 ($)
Table 83: Israel Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2019-2024 ($)
Table 84: Top Companies 2018 (US$) Cancer Testing/Screening Market, Revenue & Volume
Table 85: Product Launch 2018-2019 Cancer Testing/Screening Market, Revenue & Volume
Table 86: Mergers & Acquistions 2018-2019 Cancer Testing/Screening Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Cancer Testing/Screening Market 2019-2024
Figure 2: Market Share Analysis for Cancer Testing/Screening Market 2018 (US$)
Figure 3: Product Comparison in Cancer Testing/Screening Market 2018-2019 (US$)
Figure 4: End User Profile for Cancer Testing/Screening Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Cancer Testing/Screening Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Cancer Testing/Screening Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Cancer Testing/Screening Market 2018-2019
Figure 8: Ecosystem Analysis in Cancer Testing/Screening Market 2018
Figure 9: Average Selling Price in Cancer Testing/Screening Market 2019-2024
Figure 10: Top Opportunites in Cancer Testing/Screening Market 2018-2019
Figure 11: Market Life Cycle Analysis in Cancer Testing/Screening Market
Figure 12: GlobalBy Type Cancer Testing/Screening Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Technique Cancer Testing/Screening Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Treatment Cancer Testing/Screening Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy Stage Cancer Testing/Screening Market Revenue, 2019-2024 ($)
Figure 16: GlobalBy Gender Cancer Testing/Screening Market Revenue, 2019-2024 ($)
Figure 17: Global Cancer Testing/Screening Market - By Geography
Figure 18: Global Cancer Testing/Screening Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 19: Global Cancer Testing/Screening Market CAGR, By Geography, 2019-2024 (%)
Figure 20: North America Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 21: US Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 63: U.K Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 96: China Cancer Testing/Screening Market Value & Volume, 2019-2024
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($) Cancer Testing/Screening Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Cancer Testing/Screening Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 125: Russia Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Cancer Testing/Screening Market Value & Volume, 2019-2024 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%) Cancer Testing/Screening Market 
Figure 134: Developments, 2018-2019* Cancer Testing/Screening Market 
Figure 135: Company 1 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure : : Company 8 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)